Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

EyePoint Investigative Site

Phoenix, Arizona, United States, 85020

EyePoint Investigative Site

Huntington Beach, California, United States, 92647

EyePoint Investigative Site

Oxnard, California, United States, 93036

EyePoint Investigative Site

Palm Desert, California, United States, 92211

EyePoint Investigative Site

Pasadena, California, United States, 91107

EyePoint Investigative Site

Sacramento, California, United States, 95825

EyePoint Investigative Site

Clearwater, Florida, United States, 33761

EyePoint Investigative Site

Melbourne, Florida, United States, 32901

EyePoint Investigative Site

Miami, Florida, United States, 33143

EyePoint Investigative Site

Winter Haven, Florida, United States, 33880

EyePoint Investigative Site

Lemont, Illinois, United States, 60439

EyePoint Investigative Site

Indianapolis, Indiana, United States, 46290

EyePoint Investigative Site

Lenexa, Kansas, United States, 66211

EyePoint Investigative Site

Springfield, Massachusetts, United States, 01107

EyePoint Investigative Site

Reno, Nevada, United States, 89502

EyePoint Investigative Site

Toms River, New Jersey, United States, 08755

EyePoint Investigative Site

Florence, South Carolina, United States, 38138

EyePoint Investigative Site

Ladson, South Carolina, United States, 29456

EyePoint Investigative Site

Germantown, Tennessee, United States, 38138

EyePoint Investigative Site

Austin, Texas, United States, 78705

EyePoint Investigative Site

Houston, Texas, United States, 77025

EyePoint Investigative Site

McAllen, Texas, United States, 78503

EyePoint Investigative Site

Plano, Texas, United States, 75075

EyePoint Investigative Site

San Antonio, Texas, United States, 78247

EyePoint Investigative Site

The Woodlands, Texas, United States, 77384

EyePoint Investigative Site

Bellevue, Washington, United States, 98004

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 16, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments